Can Fite Biofarma Ltd.
13F holders, Q4 2025 (December 31)15holders −1
3new positions
4sold out
$0.45avg. 13F price*
At the end of Q4 2025, 15 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings, down 1 from Q3 2025. 3 opened new positions and 4 sold out. The largest holders were Jane Street Group, LLC ($193K), Rhumbline Advisers ($56K) and Osaic Holdings, Inc. ($7K).
- Company
- Can Fite Biofarma Ltd.
- CUSIP
- 13471N300
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $204K |
| Exits | 4 | $888K |
All 13F filers, Q3 2025 → Q4 2025: 504,719 shares bought and 1,446,733 shares sold, net −942,014 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Jane Street Group, LLC | 0.00% | New | 205,004 | $193K |
| Rhumbline Advisers | 0.00% | Add +386.6% | 281,881 | $56K |
| Osaic Holdings, Inc. | 0.00% | New | 36,000 | $7K |
| UBS Group AG | 0.00% | Add +1501.1% | 20,942 | $4K |
| XTX Topco Ltd | 0.00% | New | 18,686 | $4K |
| Bogart Wealth, LLC | 0.00% | No change | 15,045 | $3K |
| Two Sigma Securities, LLC | 0.00% | Add +13.6% | 12,088 | $2K |
| Fifth Third Bancorp | 0.00% | No change | 3,000 | $600 |
| Wells Fargo & Company | 0.00% | Reduce -7.4% | 2,500 | $500 |
| Costello Asset Management, INC | 0.00% | No change | 1,000 | $200 |
| Activest Wealth Management | 0.00% | No change | 200 | $40 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 68 | $14 |
| Morgan Stanley | 0.00% | Reduce -99.7% | 33 | $7 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 20 | $4 |
| Avion Wealth | 0.00% | No change | 100 | $0 |
"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.